Brief: Cytodyn Files A Phase 2 Basket Trial With Leronlimab (Pro 140) For Treatment Of All Solid Tumor Cancers
06/02/2020 12:05
Feb 6 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN FILES A PHASE 2 BASKET TRIAL WITH LERONLIMAB (PRO
140)
FOR TREATMENT OF ALL SOLID TUMOR CANCERS
Source text for Eikon: ID:nGNX4k05SD
Further company coverage: CYDY.PK
((Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer